Literatur
Lampl C, Likar R (2014) Metamizol: Wirkmechanismen, Interaktionen und Agranulozytoserisiko. Schmerz 28:584–590
Pierre SC, Schmidt R, Brenneis C et al (2007) Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol 151:494–503
Rogosch T, Sinning C, Podlewski A et al (2012) Novel bioactive metabolites of dipyrone (metamizol). Bioorg Med Chem 20(1):101–107
Siebel JS, Beirith A, Calixto JB (2004) Evidence for the involvement of metabotropic glutamatergic, neurokinin 1 receptor pathways and protein kinase C in the antinociceptive effect of dipyrone in mice. Brain Res 1003:61–67
Interessenkonflikt
K. Güttler gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Güttler, K. Metamizol. Schmerz 29, 227–228 (2015). https://doi.org/10.1007/s00482-015-1520-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00482-015-1520-0